Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text |  PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_31_2023 |
9,695 | 85,361 | 95,056 |
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_39_2023 |
2,168 | 86,641 | 88,809 |
CommentaryStatus of research and publication in IndiaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_29_2023 |
4,278 | 74,867 | 79,145 |
EditorialEczema and skin allergy-focus on researchFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_29_2024 |
2,434 | 61,396 | 63,830 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_52_2023 |
7,653 | 48,040 | 55,693 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_45_2023 |
8,597 | 45,272 | 53,869 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_15_2024 |
6,245 | 44,941 | 51,186 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_14_2024 |
6,750 | 39,058 | 45,808 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2023 |
5,050 | 38,901 | 43,951 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_26_2023 |
7,360 | 30,975 | 38,335 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_44_2023 |
17,035 | 20,334 | 37,369 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_6_2024 |
11,158 | 25,097 | 36,255 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_3_2021 |
24,497 | 5,555 | 30,052 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_5_2021 |
19,712 | 8,279 | 27,991 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_9_2024 |
12,628 | 15,082 | 27,710 |
Review ArticleJAK inhibitors in dermatologyFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_7_2021 |
18,613 | 7,139 | 25,752 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_3_2024 |
3,986 | 21,387 | 25,373 |
Case ReportA novel pitch against the itchFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_13_2024 |
4,231 | 20,475 | 24,706 |
SymposiumPolymorphous light eruptionsFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_8_2024 |
10,429 | 11,580 | 22,009 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_4_2024 |
6,383 | 15,230 | 21,613 |
Review ArticleGenital contact dermatitisFull text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_56_2024 |
19,475 | 1,795 | 21,270 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_19_2024 |
4,102 | 15,766 | 19,868 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_28_2023 |
6,285 | 13,332 | 19,617 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_48_2023 |
7,594 | 11,886 | 19,480 |
Review ArticleAssessing eczema severity: A comprehensive review of scoring systemsFull text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_50_2024 |
13,051 | 5,511 | 18,562 |
Conference ReportUpcoming dermatology conferences 2025Full text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_2_2025 |
14,035 | 4,192 | 18,227 |
ImageGiant fixed drug eruptionFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_47_2023 |
3,156 | 14,900 | 18,056 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_50_2023 |
10,004 | 7,964 | 17,968 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_16_2024 |
8,514 | 9,354 | 17,868 |
SymposiumCutaneous photobiologyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_11_2024 |
6,490 | 11,272 | 17,762 |
Review ArticleA review of comorbidities in atopic dermatitisFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2024 |
7,069 | 10,114 | 17,183 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_30_2023 |
5,777 | 11,278 | 17,055 |
SymposiumChronic actinic dermatitisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_10_2024 |
7,692 | 9,192 | 16,884 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_1_2024 |
3,138 | 12,740 | 15,878 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_42_2023 |
2,648 | 13,016 | 15,664 |
ObituaryObituary – Professor Marcus Maurer (1966–2024)Full text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_47_2024 |
8,216 | 6,850 | 15,066 |
Review ArticleCyclosporine in dermatology: Evidence-based review with a special focus on recent updatesFull text | PDF Volume 4 | Supplement 1 | March 2025DOI: 10.25259/IJSA_9_2025 |
11,664 | 3,339 | 15,003 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_4_2022 |
8,096 | 6,522 | 14,618 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_20_2023 |
10,353 | 4,231 | 14,584 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_5_2024 |
4,784 | 9,465 | 14,249 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_41_2023 |
7,180 | 6,994 | 14,174 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_31_2024 |
3,394 | 10,638 | 14,032 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_25_2023 |
2,707 | 10,469 | 13,176 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_51_2023 |
4,049 | 8,962 | 13,011 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_11_2021 |
7,204 | 5,480 | 12,684 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_14_2023 |
8,661 | 3,937 | 12,598 |
Review ArticleLigelizumab: A novel molecule in the management of chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_8_2023 |
6,917 | 5,642 | 12,559 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_12_2021 |
8,811 | 3,605 | 12,416 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_30_2024 |
4,786 | 7,496 | 12,282 |
Review ArticleA review of biological agents and small molecules in the management of atopic dermatitisFull text | PDF Volume 2 | Issue 2 | July-December 2023DOI: 10.25259/IJSA_18_2023 |
6,975 | 5,020 | 11,995 |